Patel Samir Rashmikant
Insider CIK 1702447 · CYDY Director · AKTX Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKTX Akari Therapeutics Plc | A Award | 2026-10-05 | 2026-10-16 | 2,236 | $7.90 | $17.7K | 12,102 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2026-08-18 | 2026-10-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2026-08-18 | 2026-10-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2026-08-18 | 2026-10-16 | 6,300 | $7.90 | $49.8K | 9,866 | SEC↗ |
| AKTX Akari Therapeutics Plc | M Exercise deriv | 2026-07-07 | 2026-07-17 | 1,209 | $32.00 | $38.7K | 0 | SEC↗ |
| AKTX Akari Therapeutics Plc | M Exercise deriv | 2026-07-07 | 2026-07-17 | 15,466 | $16.16 | $249.9K | 0 | SEC↗ |
| AKTX Akari Therapeutics Plc | M Exercise deriv | 2026-07-07 | 2026-07-17 | 5,799 | $16.16 | $93.7K | 0 | SEC↗ |
| AKTX Akari Therapeutics Plc | M Exercise | 2026-07-07 | 2026-07-17 | 5,799 | — | $0 | 98,241 | SEC↗ |
| AKTX Akari Therapeutics Plc | M Exercise | 2026-07-07 | 2026-07-17 | 15,466 | — | $0 | 92,442 | SEC↗ |
| AKTX Akari Therapeutics Plc | M Exercise | 2026-07-07 | 2026-07-17 | 1,209 | $8.00 | $9.7K | 76,976 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 231,997 | $0.40 | $92.8K | 231,997 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 618,658 | — | $0 | 618,658 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 618,658 | $0.40 | $247.5K | 618,658 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 231,997 | — | $0 | 231,997 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-20 | 2025-03-24 | 175,000 | — | $0 | 175,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-20 | 2025-03-24 | 225,000 | — | $0 | 225,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-06 | 2025-03-10 | 406,250 | $1.12 | $455.0K | 406,250 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-06 | 2025-03-10 | 406,250 | $1.12 | $455.0K | 406,250 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2025-03-06 | 2025-03-10 | 406,250 | $1.12 | $455.0K | 3,031,005 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-01-03 | 2025-01-07 | 152,672,000 | — | $0 | 152,672,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2025-01-03 | 2025-01-07 | 208,000 | — | $0 | 5,249,511,500 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2024-12-27 | 2024-12-30 | 400,000 | — | $0 | 5,249,303,500 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2024-12-26 | 2024-12-30 | 3,200,000 | — | $0 | 5,248,903,500 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2024-12-24 | 2024-12-27 | 7,500,000 | — | $0 | 5,245,703,500 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2024-12-23 | 2024-12-26 | 1,400,000 | — | $0 | 5,238,203,500 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2024-12-20 | 2024-12-26 | 1,400,000 | — | $0 | 5,236,803,500 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2024-12-02 | 2024-12-03 | 419,286,000 | — | $0 | 419,286,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2024-12-02 | 2024-12-03 | 419,286,000 | — | $0 | 5,235,403,500 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2024-11-30 | 2024-12-03 | 162,604,000 | — | $0 | 162,604,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2024-11-14 | 2024-11-18 | 1,404,622,000 | — | $0 | 4,816,117,500 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2024-10-31 | 2024-11-01 | 79,684,000 | — | $0 | 79,684,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2024-09-30 | 2024-10-02 | 175,080,000 | — | $0 | 175,080,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2024-06-30 | 2024-07-02 | 91,396,000 | — | $0 | 91,396,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2024-05-31 | 2024-06-04 | 1,326,258,000 | — | $0 | 1,326,258,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2024-05-31 | 2024-06-04 | 1,326,258,000 | — | $0 | 3,411,495,500 | SEC↗ |
| CYDY CytoDyn Inc. | D To issuer deriv | 2021-11-24 | 2021-11-29 | 225,000 | — | $0 | 0 | SEC↗ |
| CYDY CytoDyn Inc. | A Award deriv | 2021-11-24 | 2021-11-29 | 93,750 | — | $0 | 93,750 | SEC↗ |
| CYDY CytoDyn Inc. | D To issuer deriv | 2021-11-24 | 2021-11-29 | 225,000 | — | $0 | 0 | SEC↗ |
| CYDY CytoDyn Inc. | A Award deriv | 2021-11-24 | 2021-11-29 | 225,000 | — | $0 | 225,000 | SEC↗ |
| CYDY CytoDyn Inc. | D To issuer deriv | 2021-11-24 | 2021-11-29 | 12,329 | — | $0 | 0 | SEC↗ |
| CYDY CytoDyn Inc. | A Award deriv | 2021-11-24 | 2021-11-29 | 12,329 | — | $0 | 12,329 | SEC↗ |
| CYDY CytoDyn Inc. | D To issuer deriv | 2021-11-24 | 2021-11-30 | 12,329 | — | $0 | 0 | SEC↗ |
| CYDY CytoDyn Inc. | A Award deriv | 2021-11-24 | 2021-11-30 | 12,329 | — | $0 | 12,329 | SEC↗ |
| CYDY CytoDyn Inc. | A Award deriv | 2021-11-24 | 2021-11-30 | 225,000 | — | $0 | 225,000 | SEC↗ |
| CYDY CytoDyn Inc. | D To issuer deriv | 2021-11-24 | 2021-11-30 | 225,000 | — | $0 | 0 | SEC↗ |
| CYDY CytoDyn Inc. | A Award deriv | 2021-11-24 | 2021-11-30 | 112,500 | — | $0 | 112,500 | SEC↗ |
| CYDY CytoDyn Inc. | D To issuer deriv | 2021-11-24 | 2021-11-30 | 225,000 | — | $0 | 0 | SEC↗ |
| CYDY CytoDyn Inc. | A Award deriv | 2021-10-18 | 2021-10-20 | 225,000 | — | $0 | 225,000 | SEC↗ |
| CYDY CytoDyn Inc. | A Award deriv | 2020-06-25 | 2020-06-26 | 225,000 | — | $0 | 225,000 | SEC↗ |
| CYDY CytoDyn Inc. | A Award deriv | 2020-04-17 | 2020-04-22 | 12,329 | $2.25 | $27.7K | 12,329 | SEC↗ |